Takeo Shibata

Assistant Professor

University of Arkansas for Medical Sciences

faculty

12 h-index 64 pubs 479 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Takeo Shibata's research focuses on cancer immunotherapy and reproductive immunology, with a specific emphasis on cervical cancer and related conditions. His work investigates the effectiveness of various therapeutic approaches, including therapeutic vaccines, immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS), and novel treatments for cervical intraepithelial neoplasia.

His publications also explore diagnostic methods and epidemiological studies related to human papillomavirus (HPV). This includes evaluating DNA extraction protocols for studying cervical microbiota, comparing HPV tests, and assessing the effectiveness of prophylactic HPV vaccines. Additionally, Shibata has conducted research on maternal postpartum depression and psychosocial factors, as well as the role of amniotic fluid in fetal brain development.

Shibata holds an h-index of 12 with 64 total publications and 479 citations. He has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Mayumi Nakagawa, Hannah Coleman, Yong‐Chen Lu, and Teresa Evans, with whom he shares multiple publications. He has received recognition for his research, including multiple awards from Kanazawa Medical University and the UAMS Student Research Day.

Metrics

  • h-index: 12
  • Publications: 64
  • Citations: 479

Selected Publications

  • A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025) DOI
  • Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus <i>Candida</i> adjuvant alone in treating cervical intraepithelial neoplasia 2/3. (2024) DOI
  • A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI
  • Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed (2021) DOI
  • Evaluation of DNA extraction protocols from liquid-based cytology specimens for studying cervical microbiota (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics